Soaring Stock To Consider: Momenta Pharmaceuticals (NASDAQ: MNTA)

Momenta (NASDAQ: MNTA) is quickly popping after a successful buyout deal with Johnson and Johnson. Actually, MNTA is long term surging stock with negative EPS but volatile revenue.

On Tuesday MNTA grew by 5.05% adding 1.48 points to humble $30.81 price. Right now it is surpassing $50, making an all-time high record since its IPO. Demand from investors may surely push today’s volume to millions of shares.

Even though Momenta is reporting the net loss for long, investors do not run away by selling out MNTA shares. Conversely, even long term traders will buy it with enthusiastic forecasts due to its some best selling products that are on shelves of drug stores around the globe.

Alex Krakowsky

Editor in Chief.Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life